MSN Domestic Formulations Business Enters India’s Top 50 Pharmaceutical Companies

MSN’s Domestic Formulations Business has achieved a proud milestone by entering the Top 50 Pharmaceutical Companies in India for the month of November 2025. This accomplishment reflects one of the fastest scale-ups in the industry, marked by a consistent upward trajectory in the IPM rankings over the past five years. From steady progress to a breakthrough leap, this achievement highlights the power of vision, strategy, and collective determination.

This milestone is a celebration of the unwavering efforts of MSNites across functions who have worked with passion, precision, and purpose to strengthen MSN’s domestic footprint. It also underscores MSN’s commitment to expanding access to affordable, high-quality medicines and bridging critical therapy gaps in the Indian healthcare landscape. Entering the Top 50 is not just a rank  it is a reflection of trust earned, momentum built, and ambition realized.

Sharing his thoughts on this achievement, Mr. Ashish Gupta, Head of Domestic Formulations- Sales and Marketing said:

“A Proud Milestone: Entering the Top 50 in India!
Thrilled to announce that MSN Domestic Formulations Business has entered among the Top 50 Pharmaceutical Companies in India for the November month! This achievement marks one of the fastest scale-ups in the industry, leading to a significant rank jump in the IPM.
This milestone is not just a number; it is the result of a clear strategic vision, relentless dedication, and the hard work of my entire team. A special note of gratitude goes to our senior management, particularly Bharat Reddy and Dr. MSN Reddy, for their unwavering guidance and support.
We view this ranking not as a destination, but as an accelerated pedestal to push ourselves further. We are committed to raising the bar, bridging therapy gaps, and alleviating the burden on Indian patients by providing affordable, bioequivalent quality medicines.
Here is to serve our stakeholders better & better every day!”

As MSN continues its growth journey, this recognition strengthens our resolve to scale new heights, deepen our impact in healthcare, and stay true to our purpose of delivering better medicines for a healthier tomorrow.

The journey forward is faster, stronger, and together.